Oxaliplatin Medac (oxaliplatin for injection) is an antineoplastic agent for the treatment of colorectal cancer. Oxaliplatin is an organoplatinum complex in which the platinum atom is complexed with 1, 2-diaminocyclohexane (DACH) and with an oxalate ligand as a leaving group.
Oxaliplatin medac Injection 50/100/150mg
Generic Name: Oxaliplatin
Indications Adjuvant treatment of stage III colon cancer (Duke’s C) post-tumor resection, combined with 5-fluorouracil (5-FU) and folinic acid (FA).
Metastatic colorectal cancer, in combination with 5-FU and FA.
Treatment of various carcinomas, including breast, esophagus, gastric, pancreas, hepatobiliary, kidney, lung, rectal, ovarian, as well as lymphomas, mesotheliomas, and sarcomas.
Strength 5 mg/ml
Pack Size Single-use vial
Dosage Form Powder for solution for infusion
Categories Pharmaceuticals
Therapeutic Class Antineoplastic Agent (Platinum-based)